Weight Loss using this novel agent, IGOB131,should
be undertaken while under the supervision of a
physician. This historic study demonstrated more
weight loss in a shorter period of time than any other
compound ever tested. Participants took one capsule
prior to lunch and one capsule prior to dinner for ten
weeks. Participants in the study had
significant improvements in body composition and
reductions in blood measurements of cardiovascular
and diabetes risk. Again, NO changes were made to
their existing diets and no recommendations on
exercise were made.
Precautions- this approach to weight loss is not intended
for everyone. I will be discussing this breakthrough with
each of my patients on an individual basis. Medical
supervision is required because this approach may lower
cholesterol and blood sugar significantly.
Optimal cholesterol levels range from 180-200 mg/dL.
The goal is to have an LDL (bad cholesterol) of 100
mg/dL and an HDL (good cholesterol) above 60. In
this clinical trial, LDL was decreased by 27%. While
cholesterol over 200 mg/dL increases heart attack risk,
a cholesterol below 150-160 mg/dL seems to increase
risk of death. All hormones are made from cholesterol.
Type 2 Diabetics taking medications to lower blood
sugar will also need very close supervision if using
IGOB131 for weight loss. In this clinical trial, blood
sugar was decreased by 22%. This was believed to be
due to the fact that IGOB131 reduces the absorption of
sugar. If a Type 2 Diabetic experiences significant
weight loss from this approach, their need for
medication may be reduced or eliminated.
Full Story
How IGOB131 Works:
